# Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

> **NCT07553468** · NA · COMPLETED · sponsor: **Michael H Carstens** · enrollment: 8 (actual)

## Conditions studied

- Diabetic Foot
- Diabetic Peripheral Neuropathy

## Interventions

- **BIOLOGICAL:** Adipose-derived Stromal Vascular Fraction Cells

## Key facts

- **NCT ID:** NCT07553468
- **Lead sponsor:** Michael H Carstens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-03-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07553468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07553468, "Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07553468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*